Editas Medicine is a leading genome editing company focused on translating the power and promise of our proprietary genome editing systems into medicines to help transform the lives of people with genetically-defined diseases. Their goal is to discover, develop, manufacture, and commercialize transformative medicines for a range of serious diseases, including eye diseases, blood diseases, and cancer. 

Biotechnology

Editas Medicine

Gilmore O’Neill

Erick J. Lucera

Greg Whitehead

Baisong Mei

Caren Deardorf

Linda C. Burkly

Linea Aspesi

Charlene Stern

Chi Li

The executive team at Editas Medicine has a history in both the business and medical industries. The team members have worked at various companies, including HG III Consulting, Patheon, Pfizer, Baxter, and Biogen Idec. They have also been educated at East Tennessee State University, Villanova University, and Rensselaer Polytechnic Institute.

CEO and Executive Team

Leadership Team

Board of Directors

CEO and Executive Team

About

Team members

Other teams at Editas Medicine

Leadership Team

Board of Directors